In this Pharmaceutical Executive video interview, Chris Dowd, senior vice president of market development, ConnectiveRx, discusses the evolution of drug copay adjustment programs and the circumstances that fueled their controversy across industry, political, and healthcare community circles.
Behind the Push and Pull of Copay Accumulator Programs
Posted on by admin
1 min read
+ There are no comments
Add yours